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rug addiction manifests clinically as compulsive drug seeking, drug 
use, and cravings that can persist and recur even after extended 
periods of abstinence. From a psychological and neurological per-
spective, addiction is a disorder of altered cognition. The brain regions and 
processes that underlie addiction overlap extensively with those that are involved 
in essential cognitive functions, including learning, memory, attention, rea-
soning, and impulse control. Drugs alter normal brain structure and function 
in these regions, producing cognitive shifts that promote continued drug use 
through maladaptive learning and hinder the acquisition of adaptive behaviors 
that support abstinence.
In a 2005 review, Steven Hyman stated the current neurological conception 
of drug abuse concisely: Characterizing addiction as a disease of “pathological 
learning,” he wrote, “[A]ddiction represents a pathological usurpation of the 
neural mechanisms of learning and memory that under normal circumstances 
serve to shape survival behaviors related to the pursuit of rewards and the cues 
that predict them.”
This article reviews current knowledge on the cognitive effects of drugs and their 
neurological underpinnings. These effects may be particularly disruptive when 
individuals are exposed to drugs during brain development, which lasts from the 
prenatal period through adolescence, and in individuals with mental disorders. 
An understanding of these issues will help substance abuse clinicians identify 
and respond to cognitive changes that affect patients’ responses to treatment. 
Addiction and Cognition
T
he brain regions and neural processes that underlie addiction overlap extensively with those that support cognitive func-
tions, including learning, memory, and reasoning. Drug activity in these regions and processes during early stages of 
abuse foster strong maladaptive associations between drug use and environmental stimuli that may underlie future cravings  
and drug-seeking behaviors. With continued drug use, cognitive deficits ensue that exacerbate the difficulty of establishing sus-
tained abstinence. The developing brain is particularly susceptible to the effects of drugs of abuse; prenatal, childhood, and ado-
lescent exposures produce long-lasting changes in cognition. Patients with mental illness are at high risk for substance abuse, 
and the adverse impact on cognition may be particularly deleterious in combination with cognitive problems related to their  
mental disorders.r e S e a r c H   r e v i e w — a D D i c t i o n   a n D   c o G n i t i o n   •   5
a mUltiStaGe proceSS
Recent reviews characterize addiction as a two-stage 
process. In the first stage, the individual’s occasional 
drug taking becomes increasingly chronic and uncon-
trolled. The neurological source of these symptoms is 
drug-induced deregulation of the brain’s reward system 
(Feltenstein and See, 2008). Normally, increased dopa-
mine signaling within this system—specifically, in the 
ventral striatum or nucleus accumbens (NAc)—produces 
pleasurable feelings that orient organisms to seek and 
perform life-sustaining conditions and activities, such 
as locating supportive environments, eating, and having 
sex. Drugs of abuse hyperactivate this system, triggering 
abrupt and large increases in NAc dopamine signaling, 
producing intense sensations that motivate additional 
drug taking, and promoting the formation of maladaptive 
drug-stimulus associations (Feltenstein and See, 2008).
Individuals in the second stage of the addictive 
process present additional clinical features, including 
withdrawal symptoms during early abstinence, persistent 
vulnerability to relapse, and alterations in decisionmaking 
and other cognitive processes. Although modification of 
the dopaminergic reward system remains important at 
this stage, it probably is not sufficient to maintain these 
complex and long-lasting changes. Kalivas and Volkow 
(2005) summarize evidence implicating drug-induced 
alterations in signals carried by the neurotransmitter 
glutamate from the brain area that is primarily associated 
with judgment—the prefrontal cortex—to the NAc. 
Le Moal and Koob (2007) emphasize changes in brain 
stress circuits and negative reinforcement (i.e., effects 
that motivate drug taking by causing discomfort during 
abstinence, such as the onset of withdrawal symptoms). 
Thus, whereas early drug use fosters maladaptive drug-
stimulus associations that contribute to drug seeking and 
use, later stages disrupt cognitive and other processes 
that are important for successful abstinence.
The full extent of drugs’ impacts on cognition is 
not yet known, but research indicates that addicted 
individuals have alterations in brain regions includ-
ing the striatum, prefrontal cortex, amygdala, and 
hippocampus (Jones and Bonci, 2005; Kalivas and 
Volkow, 2005; Kelley, 2004; Le Moal and Koob, 2007). 
These same regions underlie declarative memory—the 
memories that define an individual, without which it 
would be difficult to generate and maintain a concept 
of self (Cahill and McGaugh, 1998; Eichenbaum, 
2000; Kelley, 2004; Setlow, 1997). Drugs’ capacity to 
act upon the substrates of declarative memory suggests 
that their impact on cognition is potentially extremely 
far-reaching.
coGnitive effectS of acUte DrUG 
aDminiStration
Clinicians often observe that patients undergoing treat-
ment for addiction become highly vulnerable to relapse 
when they return to contexts or environments where 
their addiction developed (Hyman, 2005; See, 2005). 
Clinical research confirms that cues associated with sub-
stance abuse elicit physiological responses and cravings 
for drugs (Franklin et al., 2007). Laboratory animals, 
too, develop powerful associations and cue-response 
behaviors in the presence of drug-related stimuli. For 
example, animals given a drug in one compartment of a 
double cage subsequently will gravitate to that compart-
ment more than to the alternative compartment. This 
phenomenon, known as conditioned place preference, 
has been demonstrated in studies using nicotine, ethanol, 
amphetamine, methamphetamine, cocaine, morphine, 
cannabis, and caffeine (Bardo and Bevins, 2000).
the formation of Drug-Stimulus associations
The multistage model of addiction attributes addicted 
individuals’ strong responses to drug cues to a learning 
process that inculcates powerful drug-stimulus associa-
tions (e.g., Robinson and Berridge, 2000). In this view, 
the individual taking a drug perceives his or her present 
surroundings as highly significant (salient) and makes 
exceptionally strong mental connections between features 
of those surroundings and the intense pleasure of the 
drug. Subsequently, when he or she re-encounters those 
features, the powerful associations reassert themselves, 
consciously or subconsciously, and are experienced as 
prompts for drug seeking and drug taking. Consistent 
with this account, exposing addicted individuals to cues 
that they associate with substance abuse elicits, along with 
physiological responses and drug cravings, changes in the 
activity levels of brain regions involved in learning and 
memory (i.e., striatum, amygdala, orbitofrontal cortex, 
hippocampus, thalamus, and left insula) (Franklin et al., 
2007; Volkow et al., 2006).
The acute effects of amphetamine, nicotine, and 
cocaine fit straightforwardly into this scenario. Each of 
these drugs has been shown to acutely enhance learn-
ing and/or attention (Del et al., 2007; Kenney and 
Gould, 2008; Mattay, 1996). For example, the idea 
that smoking is a cognitive enhancer is well accepted by 
researchers and the general public. Numerous studies 
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have confirmed that laboratory animals’ cognitive pro-
cesses improve immediately following administration of 
nicotine (Kenney and Gould, 2008). Similar findings in 
early studies with human smokers were not conclusive, 
because the study participants were smokers who had 
received nicotine following a period of abstinence. The 
observed enhancements might have reflected the reversal 
of withdrawal effects, rather than improvements over 
their normal cognitive powers. A subsequent review 
of the literature, however, suggests that acute nicotine 
enhances reaction time and attention in nicotine-naïve 
individuals (Swan and Lessov-Schlaggar, 2007). Cocaine 
produced similar effects in a study of rats that were treated 
with the drug and then exposed to a sensory stimulus; 
the animals exhibited enhanced neural activation when 
later re-exposed to the stimulus (Devonshire, Mayhew, 
and Overton, 2007).
Although all drugs of abuse foster the learning of 
strong drug-stimulus associations and cue-induced drug 
seeking, some appear to have mixed effects on other types 
of learning and cognition. For example, a clinical study of 
the acute effects of morphine and oxycodone concluded 
that these drugs have variable impacts on cognition: 
Both improved men’s recall of prose just slightly, but 
morphine slightly impaired both sexes’ performance 
on a test of working memory in which they were asked 
to repeat a set of digits in reverse order (Friswell et al., 
2008). In another study, mice were given morphine or 
saline and trained to run away when a light signaled that 
a foot shock was impending; although the morphine-
treated mice scored higher on the frequency and quick-
ness with which they avoided shocks, the researchers 
attributed this to increased motor activity rather than 
enhanced learning (Aguilar, Miñarro, and Simón, 1998). 
In contrast to the effects of opioids on cognition, those 
of alcohol are clear, though bidirectional: High doses 
disrupt cognitive processes (Ryback, 1971), while low 
doses can enhance learning (Gulick and Gould, 2007; 
Hernández, Valentine, and Powell, 1986).
the persistence of Drug-Stimulus associations
Recent research has sought to account for the strik-
ingly long-lasting ability of maladaptive drug-stimulus 
associations to influence behavior and provoke relapse. 
Studies have shown that many abused substances can 
reshape the communication pathways between neurons 
(synaptic plasticity), which could contribute to both 
the formation and the persistence of maladaptive drug-
stimulus associations. 
Cocaine and nicotine can directly induce one form 
of synaptic plasticity, the strengthening of neural con-
nections via a process known as long-term potentiation 
(LTP; see Learning in the Mind and Brain on page 8 
and Table 1) (Argilli et al., 2008; Kenney and Gould, 
2008). Amphetamine can enhance LTP (Delanoy, Tucci, 
and Gold, 1983). Marijuana activates the endocannabi-
noid system, resulting in inhibition in some instances 
and facilitation in others of both LTP and long-term 
depression (LTD), another form of synaptic plasticity 
in which connections between neurons become less 
responsive (Carlson, Wang, and Alger, 2002;  Nugent 
and Kauer, 2008; Sullivan, 2000). Ethanol consistently 
disrupts LTP while enhancing LTD (Yin et al., 2007). 
Morphine inhibits LTP of neurons that exhibit inhibi-
tory control of neural activity via the neurotransmitter 
gamma-aminobutyric acid (GABA) (Nugent and Kauer, 
2008). Inhibition of GABA activity could lead to an 
overall increase in neural activity throughout the brain, 
which might lead to the formation of stronger associa-
tions than would normally occur, including maladaptive 
drug-context associations.
Strengthening the evidence that drugs foster long-
lasting drug-stimulus associations by affecting synap-
tic plasticity, studies have demonstrated that the same 
proteins that participate in the sequential biochemical 
reactions (cell signaling cascades) that control synaptic 
plasticity (see Figure 1) come into play in drug-seeking 
behaviors. For example, in one experiment, researchers 
showed that when rats went to a cage area that they 
had been trained to associate with cocaine, the levels of 
proteins associated with learning—extracellular signal-
regulated protein kinase (ERK), cyclic AMP response 
element-binding (CREB), Elk-1, and Fos—increased in 
DrUG        effectS on plaSticity
Amphetamine      LTP
Cocaine        LTP
Ethanol        LTP, LTD
Marijuana      LTP, LTD
Morphine      LTP (of inhibitory synapses)
Nicotine       LTP
taBle 1. Drug effects on Synaptic plasticity
ltp, long-term potentiation of synaptic efficiency; ltD, long-term depression of 
synaptic efficiency.
High doses  
of alcohol  
disrupt cogni-
tive processes, 
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doses can 
enhance  
learning.their NAc (Miller and Marshall, 2005). Moreover, when 
the rats were treated with a compound that suppresses 
ERK, they stopped preferring that cage area over one in 
which they had received saline and showed a decrease in 
three biochemical participants in LTP (CREB, Elk-1, 
and Fos) in the NAc.
coGnitive DeficitS in cHronic DrUG 
aBUSe
Drug abusers who progress to the second stage of addic-
tion are subject to withdrawal when they initiate absti-
nence. Many drugs produce cognition-related withdrawal 
symptoms that may make abstinence more difficult. 
These include: 
• cocaine—deficits in cognitive flexibility (Kelley et al., 
2005); 
• amphetamine—deficits in attention and impulse con-
trol (Dalley et al., 2005); 
• opioids—deficits in cognitive flexibility (Lyvers and 
Yakimoff, 2003); 
• alcohol—deficits in working memory and attention 
(Moriyama et al., 2006); 
• cannabis—deficits in cognitive flexibility and attention 
(Pope, Gruber, and Yurgelun-Todd, 2001); and 
• nicotine—deficits in working memory and declarative 
learning (Kenney and Gould, 2008). 
Nicotine provides a familiar example of cognitive 
changes in withdrawal. In both chronic smokers and 
animal models of nicotine addiction, cessation of nico-
tine administration is associated with deficits in work-
ing memory, attention, associative learning, and serial 
addition and subtraction (Bell et al., 1999; Blake and 
Smith, 1997; Davis et al., 2005; Hughes, Keenan, and 
Yellin, 1989; Jacobsen et al., 2006; Mendrek et al., 2006; 
Raybuck and Gould, 2009; Semenova, Stolerman, and 
Markou, 2007). Moreover, it has been shown that the 
severity of decreases in cognitive performance during 
periods of smoking abstinence predicts relapse (Patter-
son et al., 2010; Rukstalis et al., 2005). Although these 
deficits usually dissipate with time, a dose of nicotine 
will rapidly ameliorate them (Davis et al., 2005)—a 
situation that may contribute to some relapses. Thus, 
chronic substance abuse can lead to cognitive deficits 
that are particularly pronounced during early periods 
of abstinence. 
While the cognitive deficits associated with with-
drawal from drugs are often temporary, long-term use 
can also lead to lasting cognitive decline. The nature of 
deficits varies with the specific drug, the environment, 
and the user’s genetic makeup (see Genes, Drugs, and 
Cognition on page 11). In general, however, they impair 
the ability to learn new patterns of thought and behavior 
that are conducive to successful response to treatment 
and recovery. 
For example, long-term cannabis users have impaired 
learning, retention, and retrieval of dictated words, and 
both long-term and short-term users show deficits in 
time estimation (Solowij et al., 2002), although how 
long these deficits persist is not yet known. As another 
example, chronic amphetamine and heroin users show 
deficits in a range of cognitive skills, including verbal 
fluency, pattern recognition, planning, and the ability 
to shift attention from one frame of reference to another 
(Ornstein et al., 2000). The decisionmaking deficits 
resembled those observed in individuals with damage 
to the prefrontal cortex, suggesting that both drugs alter 
function in that brain area (Rogers et al., 1999).
A pair of recent studies suggests that some meth-
amphetamine-induced cognitive losses may be partially 
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Glutamate binds to α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (ampa) 
and n-methyl-d-aspartic acid (nmDa) receptors in the neuron membrane, open-
ing channels for sodium and calcium to flow into the cell; calcium influx induces 
adenylate cyclase to convert adenosine triphosphate (atp) to cyclic adenosine 
monophosphate (camp). camp triggers activation, sequentially, of protein kinase 
a (pKa), mitogen-activated protein kinase/extracellular signal-regulated protein 
kinase (mapK/erK), and camp response element-binding (creB). creB attaches 
to Dna, increasing Dna production of protein for the construction of new syn-
apses. (for a detailed review of the cellular substrates of learning, see abel and 
lattal, 2001.)
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fiGUre 1. a cell Signaling cascade in learning and memory
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recouped with extended abstinence (Volkow et al., 
2001; Wang et al., 2004). Evaluated when abstinent 
for less than 6 months, chronic methamphetamine 
abusers scored lower than unexposed controls on tests of 
motor function, memory for spoken words, and other 
neuropsychological tasks. The deficits were associated 
with a comparative scarcity of dopamine transporters 
(proteins that regulate dopamine) and reduced cellular 
activity (metabolism) in the thalamus and NAc. When 
retested after 12 to 17 months of abstinence, the drug 
abusers’ motor function and verbal memory had risen 
to levels that approached those of the control group, 
and the gains correlated with a return toward normal 
transporter levels in the striatum and metabolic levels 
in the thalamus; however, other neuropsychological 
deficits remained, along with depressed metabolism 
in the NAc. 
In another study, abusers of 3,4-methylenedioxy-
methamphetamine (MDMA, ecstasy) continued to 
score relatively poorly in tests of immediate and delayed 
recall of spoken words even after 2.5 years of abstinence 
(Thomasius et al., 2006). In a study of polydrug abusers 
who had stated a primary preference for either cocaine 
or heroin, deficits in executive function—defined as 
changes in fluency, working memory, reasoning, response 
inhibition, cognitive flexibility, and decisionmaking—
remained after up to 5 months of abstinence (Verdejo-
García, and Pérez-García, 2007). 
An important question is whether nicotine’s cogni-
tive benefit persists as smoking shifts from sporadic 
to chronic. In some studies with animals, chronic 
nicotine administration improved cognitive capacities 
such as attention, but other studies found that initial 
improvements waned with chronic treatment (Kenney 
and Gould, 2008). Furthermore, several recent studies 
have shown that smoking and a past smoking history 
are associated with cognitive decline. For example, in 
one study with middle-aged men and women, smokers’ 
cognitive speed declined nearly twice as much as non-
smokers’ over 5 years; in addition, declines in smokers’ 
cognitive flexibility and global cognition occurred at 2.4 
times and 1.7 times the respective rates of nonsmokers 
(Nooyens, van Gelder, and Verschuren, 2008). Recent 
quitters’ scores in these areas were similar to smokers’, 
and ex-smokers performed at levels intermediate between 
smokers and nonsmokers. 
Similarly, in another study, smokers’ performance 
deteriorated more over 10 years than nonsmokers’ on 
tests of verbal memory and speed of visual searching; 
ex-smokers’ visual search speed slowed more than non-
smokers’ as well (Richards et al., 2003). Although some 
early studies suggested that smoking might retard the 
cognitive decline associated with Alzheimer’s disease 
(van Duijn and Hofman, 1991), followup studies failed 
learninG in tHe minD anD Brain
A mind learns: It captures and stores information and impressions and 
discovers relationships between them. For the mind to learn, events 
must occur in the brain. Among the most compelling pieces of evidence 
for this idea are many cases of individuals who suffered drastic reduc-
tions of their ability to learn after incurring brain injuries. The most 
famous, perhaps, is Henry Molaison, who, after surgical removal of 
extensive brain tissue at age 27 to control his epilepsy, entirely lost his 
long-term declarative memory (Penfield and Milner, 1958) so that for the 
remaining 55 years of his life he could not call to mind anything that hap-
pened to him more than a few minutes earlier.
Neuroscience research has correlated learning with the elaboration of 
neural networks in the brain. Many experiments have established that, as 
learning takes place, selected neurons increase their levels of activity and 
form new connections, or strengthen established connections, with net-
works of other neurons. Moreover, experimental techniques that prevent 
neuronal activity and networking inhibit learning.
Neuroscience research with animals is elucidating how the brain con-
structs and maintains the neural networks that support learning. One 
process identified, long-term potentiation (LTP), has features that paral-
lel key aspects of learning.
•  Once we learn to associate two ideas or sensations, the occurrence 
of one is likely to invoke remembrance of the other. Similarly, in LTP, 
a neuron that receives strong, or high-frequency, stimulation from 
another neuron responds by becoming more sensitive to future stimu-
lation from the same source;
•  Newly learned material enters our short-term memory and may or may 
not subsequently become established in our long-term memory. Simi-
larly, LTP has an early phase during which short-term physiological pro-
cesses support the above-mentioned increase in neuronal sensitivity 
and a late phase involving more long-lasting physiological processes;
•  Animal studies have implicated some of the same sequences of 
biochemical changes (cell signaling cascades) in LTP and learning. 
For example, researchers showed that suppressing production of an 
enzyme (protein kinase A) in the hippocampi of mice prevented LTP 
and inhibited the animals’ ability to retain previously learned informa-
tion about a maze (Abel et al., 1997).
Although LTP has not been observed in every brain region, it has been 
demonstrated in the nucleus accumbens, prefrontal cortex, hippocam-
pus, and amygdala—all regions involved in both addiction and learning 
(Kenney and Gould, 2008; Kombian and Malenka, 1994; Maren, 2005; 
Otani et al., 2003).to confirm this, and others correlated smoking quantity 
and duration with higher risk for Alzheimer’s disease 
(Swan and Lessov-Schlaggar, 2007).
Laboratory studies have demonstrated nicotine-
related alterations in neuronal functioning that could 
underlie cognitive decline that persists even after pro-
longed abstinence. For example, rats’ self-administration 
of nicotine was associated with a decrease in cell adhesion 
molecules, a decrease in new neuron production, and 
an increase in cell death in the hippocampus (Abrous 
et al., 2002). Such changes could result in long-lasting 
cognitive changes that contribute to poor decisionmak-
ing and addiction.
DrUGS of aBUSe anD tHe DevelopinG 
Brain 
The human brain continues to develop and consolidate 
important neural pathways from the prenatal period 
through adolescence. Throughout these years, the brain 
is highly malleable, and drug-induced alterations of 
neural plasticity may deflect the normal course of brain 
maturation.
prenatal exposures
The consequences of prenatal alcohol exposure are well-
known: Fetal alcohol spectrum disorders are the leading 
cause of mental retardation in the United States (Centers 
for Disease Control and Prevention, 2009). In addition, 
fetal alcohol exposure increases susceptibility to later 
substance abuse problems (Yates et al., 1998).
Prenatal exposures to a number of other drugs have 
significant deleterious effects on cognition and behavior 
that may not rise to the level of mental retardation. In 
one study, 5-year-olds whose mothers had used alcohol, 
cocaine, and/or opiates while pregnant ranked below 
unexposed controls in language skills, impulse control, 
and visual attention. There were no significant differ-
ences between the two groups of children in intelligence, 
visual/manual dexterity, or sustained attention; however, 
both groups placed below the normative means on these 
measures (Pulsifer et al., 2008). Another study docu-
mented memory deficits in 10-year-old children who 
had been exposed prenatally to alcohol or marijuana 
(Richardson et al., 2002). 
Clinical and laboratory research has implicated pre-
natal exposure to methamphetamine in both cognitive 
deficits and altered brain structure. For example, one 
study correlated shorter attention span and delayed 
memory with reduced volume in the putamen (-18 
percent), globus pallidus (-27 to -30 percent), and hip-
pocampus (-19 to -20 percent) among 15 children aged 
3 to 16 years who were prenatally exposed to the stimu-
lant, compared with controls (Chang et al., 2004). The 
drug-exposed children also exhibited poorer long-term 
spatial memory and visual/motor integration. Another 
study documented structural changes in the frontal and 
parietal cortex of 3- and 4-year-old children who had 
been exposed prenatally to methamphetamine (Cloak 
et al., 2009). In laboratory studies, rats that were treated 
with methamphetamine during pregnancy gave birth to 
pups that, when they reached adulthood, were slow to   
learn spatial relationships and exhibited spatial memory 
impairment (Acuff-Smith et al., 1996; Slamberová et 
al., 2005).
The effects of prenatal tobacco exposure are par-
ticularly concerning because so many expectant moth-
ers smoke—by one estimate, over 10 percent in the 
United States (Hamilton et al., 2007). In utero expo-
sure to tobacco byproducts has been linked to cognitive 
deficits in laboratory animals and human adolescents 
(Dwyer, Broide, and Leslie, 2008). Some studies sug-
gest that such exposure can lower general intelligence; 
for example, one found a 12-point gap in full-scale IQ 
between exposed and unexposed middle-class adolescents 
(e.g., Fried, Watkinson, and Gray, 2003). In another 
study, the odds of having attention deficit hyperactivity 
disorder (ADHD) were more than three times as great 
for adolescents whose mothers smoked during pregnancy 
compared with children of nonsmoking mothers (Pauly 
and Slotkin, 2008).
Cognitive deficits following prenatal exposure to 
smoking may reflect structural brain changes. In one 
study, prenatally exposed adolescent smokers had greater 
visuospatial memory deficits in conjunction with changes 
in parahippocampal and hippocampal function com-
pared with adolescent smokers not prenatally exposed 
(Jacobsen et al., 2006). Brain imaging of adolescent 
smokers and nonsmokers who were prenatally exposed 
to smoking has revealed reduced cortical thickness (Toro 
et al., 2008) and structural alterations in cortical white 
matter (Jacobsen et al., 2007). Furthermore, in rats, 
prenatal exposure to nicotine decreased memory-related 
neural activity in the hippocampus and resulted in defi-
cits in active avoidance learning, with male and female 
prenatally exposed rats showing significantly fewer cor-
rect responses as young adults (Vaglenova et al., 2008). 
These deficits persisted into later adulthood among the 
male rats, but not the females.
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Among the adverse consequences of prenatal drug 
exposure is a heightened risk of becoming a drug abuser 
in later life (Fergusson, Woodward, and Horwood, 
1998). This is troubling, as it may lead to a downward 
spiral that manifests across generations and destroys 
family structures. Multiple factors could contribute 
to the increased risk of future substance abuse, includ-
ing the effects of prenatal drug exposure on cognition. 
As already reviewed, the risk of developing ADHD is 
greatly increased in adolescents whose mothers smoked 
during pregnancy (Pauly and Slotkin, 2008). ADHD 
is often comorbid with substance abuse (Biederman et 
al., 2008; Molina and Pelham, 2003), suggesting a link 
between such changes in cognition and future drug abuse. 
Further work is needed to understand the mechanisms 
that underlie the increased risk of drug abuse associated 
with prenatal exposure. 
adolescent exposure
Adolescence is a high-risk period for substance abuse. 
Most addicted smokers first formed the habit during 
adolescence (Khuder, Dayal, and Mutgi, 1999). Ado-
lescent smoking strongly affects cognition. Adolescent 
smokers scored worse than age-matched nonsmokers on 
tests of working memory, verbal comprehension, oral 
arithmetic, and auditory memory (Fried, Watkinson, 
and Gray, 2006; Jacobsen et al., 2005). These deficits 
resolved upon cessation of smoking with the excep-
tions of working memory and arithmetic performance, 
which remained at comparatively low levels. In rats, 
nicotine exposure during adolescence was associated 
with visuospatial attention deficits, increased impul-
sivity, and increased sensitivity of medial prefrontal 
cortical dopamine terminals in adulthood (Counotte 
et al., 2009). In addition, adolescent rats treated with 
nicotine had long-lasting changes in the sensitivity of the 
adenylyl cyclase cell signaling cascade (see Figure 1), a 
second messenger pathway involved in many processes, 
including learning and memory (Slotkin et al., 2008). 
These findings fit well with studies demonstrating that 
nicotine initially can enhance some cognitive processes, 
but with continued use adaptation can occur, leading to 
dissipation of these effects and even deficits (for review, 
see Kenney and Gould, 2008).
Adolescent smoking can foster cognitive decline 
indirectly, through the promotion of other disorders. For 
example, adolescent cigarette use is associated with later 
episodes of depression (Choi et al., 1997), a malady which 
in turn is associated with negative effects on cognition 
(Thomas and O’Brien, 2008). A laboratory investigation 
shed light on this relationship: Adult rats that had been 
exposed to nicotine during their adolescence proved less 
sensitive than controls to rewarding/appetitive stimuli 
and more responsive to stress and anxiogenic stimuli 
(Iñiguez et al., 2009).
Adolescent exposures to other substances of abuse, 
such as alcohol, cannabis, and MDMA, also cause per-
sistent disruptions of cognition (Brown et al., 2000; 
O’Shea, McGregor, and Mallet, 2006; Piper and Meyer, 
2004; Stiglick and Kalant, 1982). These findings indicate 
that the adolescent brain, which is still developing, is 
susceptible to insult from drug use and abuse, and such 
insult can result in long-lasting changes in affect and 
cognition.
 
DrUGS of aBUSe anD mental illneSS
Drug-related cognitive deficits may be particularly det-
rimental to the well-being of individuals whose cogni-
tive performance is already compromised by a mental 
disorder. Moreover, individuals who suffer from mental 
disorders abuse drugs at higher rates than the general 
population. Substance abuse is almost twice as prevalent 
among adults with serious psychological distress or major 
depressive episodes as among age-matched controls 
(SAMHSA, 2007, p. 85), and it is estimated that over 
half of U.S. individuals with drug disorders (excluding 
alcohol) also have mental disorders (Regier et al., 1990). 
In a 1986 study, smoking rates approximated 30 percent 
in population-based controls, 47 percent in patients with 
anxiety disorder or major depressive disorder, 78 percent 
in patients with mania, and 88 percent in patients with 
schizophrenia (Hughes et al., 1986).
The case of smoking and schizophrenia provides 
one example of a mental disorder that features cognitive 
deficits in combination with abuse of a drug that causes 
cognitive decline. As with many comorbidities, effective 
treatment will likely require untangling the reasons why 
the two conditions so frequently co-occur:
• Some evidence suggests that patients with schizophre-
nia smoke to self-medicate. For example, smoking 
reverses schizophrenic patients’ deficits in the brain’s 
ability to adapt its responses to stimuli (sensory gating), 
which could reduce the capacity to filter information, 
and might account for some of the cognitive disruption 
seen in the mental disorder. Researchers have traced 
this feature of schizophrenia to a variant of the gene 
for the α7 nicotinic acetylcholinergic receptor subunit 
(Leonard et al., 2001). Consistent with this viewpoint 
over half of 
U.S. individu-
als with drug 
disorders 
(excluding 
alcohol) have 
co-occurring 
mental  
disorders.is an observation that patients smoke less when given 
the antipsychotic clozapine, which independently 
alleviates this deficit, than when given haloperidol, 
which does not (McEvoy, Freudenreich, and Wilson, 
1999).
• It has also been proposed that patients with schizo-
phrenia smoke to alleviate side effects of antipsychotic 
medication (Goff, Henderson, and Amico, 1992). 
An observation that supports this idea is that patients 
with schizophrenia smoke more after receiving the 
antipsychotic haloperidol than when unmedicated 
(McEvoy et al., 1995).
• Another suggested explanation for the link between 
smoking and schizophrenia is that smoking itself may 
precipitate schizophrenia in people predisposed to 
develop the disease. Among schizophrenics, smok-
ers have an earlier onset of illness, require hospital 
admissions more frequently, and receive higher doses 
of antipsychotic medications (Goff, Henderson, and 
Amico, 1992; Kelly and McCreadie, 1999; Ziedonis 
et al., 1994). 
Another cognitive disorder that is strongly associ-
ated with smoking is ADHD. Interestingly, the cogni-
tive symptoms associated with ADHD are similar to 
those displayed during nicotine withdrawal, and both 
have been attributed to alterations in the acetylcholin-
ergic system (Beane and Marrocco, 2004; Kenney and 
Gould, 2008). The high prevalence of smoking among 
individuals with ADHD (Lambert and Hartsough, 
1998; Pomerleau et al., 2003) may be an attempt to 
self-medicate, because acute nicotine use can reverse some 
ADHD attentional deficits (Conners et al., 1996). The 
desire to avoid withdrawal may be a particularly strong 
motivation for continued smoking in this population, as 
individuals with ADHD suffer more severe withdrawal 
symptoms than age-matched controls without the dis-
order (Pomerleau et al., 2003), and increases in ADHD 
symptoms following smoking cessation are associated 
with a greater risk of relapse (Rukstalis et al., 2005). As 
noted above, however, continued smoking in itself can 
lead to cognitive decline (Nooyens, van Gelder, and 
Verschuren, 2008; Richards et al., 2003), and hence 
might exacerbate ADHD-related symptoms. 
Along with nicotine, ADHD is also associated 
with abuse of stimulants, such as amphetamine and 
cocaine, and psychoactive drugs, such as cannabis (Elkins, 
McGue, and Iacono, 2007; Galéra et al., 2008; Tang et 
al., 2007). Such abuse may also represent attempts at self-
medication, as stimulants are used to treat ADHD symp-
toms (Dopheide and Pliszka, 2009; Kollins, 2008) such 
as deficits in attention and working memory (Beane and 
Marrocco, 2004). Some of the distress of ADHD may 
reflect a reduction in dopaminergic function (Volkow 
et al., 2009), which might be partially compensated by 
drugs of abuse (Feltenstein and See, 2008).
clinical implicationS
The literature reviewed here highlights the importance 
of considering past and present cognitive function when 
treating patients for addiction, as drug-related cognitive 
changes may bias patients toward responses and actions 
that contribute to the cycle of addiction. Clinicians 
face the challenge of helping patients master adaptive 
strategies to overcome the strong associations that con-
tribute to relapse when patients return to environments 
associated with their prior substance use. In addition, 
cognitive deficits may hinder patients’ ability to benefit 
from counseling, and more sessions and/or reminders 
may be necessary to aid these patients in incorporating 
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GeneS, DrUGS, anD coGnition
An individual’s genetic makeup can influence the degree to which a drug 
of abuse alters his or her cognitive processes. For instance, an individu-
al’s cognitive response to acute amphetamine depends in part on which 
of the alternative forms of the catechol-O-methyltransferase (COMT) gene 
he or she has inherited.
This gene encodes a protein that metabolizes dopamine and norepi-
nephrine, among other molecules. A person inherits two copies of 
the gene, one from each parent, and each copy has either a valine or a 
methionine DNA triplet at codon 158: thus, a person may have two valine 
(Val/Val), two methionine (Met/Met), or a mixed pair (Val/Met or Met/
Val) of codons at this location. Administration of acute amphetamine 
to individuals with the Val/Val pairing improved their performance on 
the Wisconsin Card Sorting Task (a test of cognitive flexibility that acti-
vates the dorsolateral prefrontal cortex) and increased efficiency in their 
prefrontal cortical function, as measured by increased regional cerebral 
blood flow in the inferior frontal lobe (Mattay et al., 2003). However, 
acute amphetamine did not produce those advantages in individuals 
with either the Val/Met or Met/Met pairing. Interestingly, the Val/Val 
pairing is also associated with increased impulsivity, a trait associated 
with addiction (Boettiger et al., 2007).
Furthermore, smokers with the Val/Val pairing were more sensitive to 
the disruptive effects of nicotine withdrawal on working memory and 
exhibited a greater cognitive response to tobacco (Loughead et al., 
2009). These results are important not only because they demonstrate 
a link between the effects of drugs of abuse on cognition and behavioral 
traits associated with addiction, but also because they provide examples 
of how genotype contributes to the addictive phenotype.
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abstinence-sustaining strategies into their daily routines.
Research into the changes in cognition that accom-
pany addiction and the neural substrates of learning and 
addiction is still in its infancy but has potential to reshape 
views on addiction. For example, a recent discovery that 
has generated excitement in the addiction field is that 
smokers who suffered damage to the insula often lost 
their desire to smoke (Naqvi et al., 2007). The authors 
of this finding proposed that the insula is involved in 
the conscious urge to smoke and that therapies that 
modulate insula function may facilitate smoking cessa-
tion. It may also be that damage to the insula will have 
a similar effect on the desire to use other drugs of abuse 
(for a review see Goldstein et al., 2009). 
A better understanding of how substances of abuse 
change cognitive processes is needed to develop new 
therapeutic agents to treat addiction and ameliorate 
cognitive deficits. This is a complex issue, however, as 
different drugs of abuse appear to alter different cogni-
tive processes and cell signaling pathways. Even among 
users of the same drug, cognitive impacts will differ 
depending on variations in environmental factors and 
genetics. Understanding the influence of an individual’s 
genetic background on the manifestation of symptoms is 
a critical area for future research, holding the promise of 
informing more effective treatments that can be tailored 
to the individual’s genotype. Finally, understanding 
how prenatal exposure to drugs of abuse changes neu-
ral development should be a high priority, as prenatal 
exposure increases the new generation’s susceptibility 
to addiction and other problems.
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